Modern medicine has made extraordinary progress in the last few decades. But little success has been achieved in the management of recurrent pregnancy losses and implantation failures post in vitro fertilization. It results in extreme duress and financial burden on the couples seeking treatment. To prevent such pregnancy losses a lot of new therapies are offered to them. Immunotherapies like Allogenic Lymphocyte Immunization, Corticosteroid therapy, Intravenous Immunoglobulin, etc., are being researched and tried. We searched current literature for evidence pertaining to all the different immunotherapies for treatment. We studied trials, meta-analyses and review articles on it. This review has summarized the current status of research and evidence on all these therapies. We concluded that the causation and mechanism of alteration of immune system has been well documented in most of the therapies. Clinical evidence indicating definite benefit is conflicting and at times lacking. More research and studies need to be done to validate these therapies for routine clinical use. Keywords: Recurrent pregnancy loss, Recurrent implantation failure, Immunotherapy, Abortions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.